PETER MICHALAK: Open Payments
NPI 1104321777 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 47 payments from 13 companies in 2025. Trend: 2023 $431 · 2024 $587 · 2025 $760
Food & beverage: $760
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $250 |
| Amgen Inc. | 20 | $159 |
| Exact Sciences Corporation | 3 | $58 |
| ABBVIE INC. | 3 | $57 |
| Novo Nordisk Inc | 3 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| PFIZER INC. | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $20 |
Products named: BREZTRI, AIRSUPRA, OTEZLA, EVENITY, Cologuard Collection Kit, VRAYLAR, Rybelsus, Kerendia.
Industry payments across AZ — which companies pay providers there.
